Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Büller

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Thrombosis and Haemostasis : JTH|July 17, 2015
Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai-VTE trialM Nakamura, Y Q Wang, C Wang, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 4, 2013
Venous thromboembolism: prophylactic and therapeutic practice guidelineB F Jacobson, S Louw, H Büller, et al.
Circulation|July 4, 2001
Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacementA Lee, G Agnelli, H Büller, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Thrombosis and Haemostasis : JTH|July 17, 2015
Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai-VTE trialM Nakamura, Y Q Wang, C Wang, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 4, 2013
Venous thromboembolism: prophylactic and therapeutic practice guidelineB F Jacobson, S Louw, H Büller, et al.
Circulation|July 4, 2001
Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacementA Lee, G Agnelli, H Büller, et al.
Pageof 2